Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes

Journal of Diabetes Science and Technology

Volumn 9, Issue 2, 2015, Pages 169-176

  Danese, Elisa ^a   Montagnana, Martina ^a   Nouvenne, Antonio ^b   Lippi, Giuseppe ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Diabetes; Fructosamine; Glycated albumin; Glycated hemoglobin

Indexed keywords

FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLYCOSYLATED SERUM ALBUMIN; SERUM ALBUMIN;

ANALYTIC METHOD; CAPILLARY BLOOD; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC PATIENT; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HUMAN; PATIENT MONITORING; PREGNANCY DIABETES MELLITUS; PROGNOSIS; RELIABILITY; RISK REDUCTION; SCREENING TEST; BLOOD;

BIOMARKERS; DIABETES MELLITUS; FRUCTOSAMINE; HUMANS; SERUM ALBUMIN;

EID: 84946721876     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296814567227     Document Type: Conference Paper

References (74)

1. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137-149.
2. American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care. 2014;37(suppl 1):S14-S80.
3. Lippi G, Mattiuzzi C, Targher G. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362:2030.
4. Lippi G, Targher G. Glycated hemoglobin (HbA1c): old dogmas, a new perspective? Clin Chem Lab Med. 2010;48:609-614.
5. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care. 2002;25:275-8.
6. Lippi G, Targher G. A laboratory standpoint on the role of hemoglobin A1c for the diagnosis of diabetes in childhood: more doubts than certainties? Pediatr Diabetes. 2011;12:183-186.
7. He XM, Carter DC. Atomic structure and chemistry of human serum albumin. Nature. 1992;358:209-215.
8. Zilg H, Schneider H, Seiler FR. Molecular aspects of albumin functions: indications for its use in plasma substitution. Dev Biol Stand. 1980;48:31-42.
9. Anguizola J, Matsuda R, Barnaby OS, et al. Review: glycation of human serum albumin. Clin Chim Acta. 2013;425:64-76.
10. Roohk HV, Zaidi AR. A review of glycated albumin as an intermediate glycation index for controlling diabetes. J Diabetes Sci Technol. 2008;2:1114-1121.
11. Garlick RL, Mazer JS. The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem. 1983;258:6142-6146.
12. Rondeau P, Bourdon E. The glycation of albumin: structural and functional impacts. Biochimie. 2011;93:645-658.
13. Guerin-Dubourg A, Catan A, Bourdon E, Rondeau P. Structural modifications of human albumin in diabetes. Diabetes Metab. 2012;38:171-178.
14. Lee EY, Lee BW, Kim D, et al. Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetes patients. Acta Diabetol. 2011;48:167-172.
15. Johnson RN, Metcalf PA, Baker JR. Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta. 1983;127:87-95.
16. Schleicher ED, Vogt BW. Standardization of serum fructosamine assays. Clin Chem. 1990;36:136-139.
17. Dingari NC, Horowitz GL, Kang JW, Dasari RR, Barman I. Raman spectroscopy provides a powerful diagnostic tool for accurate determination of albumin glycation. PLOS ONE. 2012;7:e32406.
18. Zhernovaya OS, Tuchin VV, Meglinski IV. Monitoring of blood proteins glycation by refractive index and spectral measurements. Laser Phys Lett. 2008;5:460-464.
19. Hinton DJS, Ames JM. Analysis of glycated protein by capillary electrophoresis. Int Congress Ser. 2002;1245:471-474.
20. Pereira Morais MP, Mackay JD, Bhamra SK, et al. Analysis of protein glycation using phenylboronate acrylamide gel electrophoresis. Proteomics. 2010;10:48.
21. Kouzuma T, Usami T, Yamakoshi M, Takahashi M, Imamura S. An enzymatic method for the measurement of glycated albumin in biological samples. Clin Chim Acta. 2002;324:61-71.
22. Kouzuma T, Uemastu Y, Usami T, Imamura S. Study of glycated amino acid elimination reaction for an improved enzymatic glycated albumin measurement method. Clin Chim Acta. 2004;346:135-143.
23. Kohzuma T, Koga M. Lucica GA-L glycated albumin assay kit: a new diagnostic test for diabetes mellitus. Mol Diagn Ther. 2010;14:49-51.
24. Montagnana M, Paleari R, Danese E, et al. Evaluation of biological variation of glycated albumin (GA) and fructosamine in healthy subjects. Clin Chim Acta. 2013;423:1-4.
25. Schleicher ED, Olgemöller B, Wiedenmann E, Gerbitz KD. Specific glycation of albumin depends on its half-life. Clin Chem. 1993;39:625-628.
26. Rodriguez-Segade S, Lojo S, Camiña MF, Paz JM, Del Río R. Effects of various serum proteins on quantification of fructosamine. Clin Chem. 1989;35:134-138.
27. Beck R, Steffes M, Xing D, et al. Diabetes Research in Children Network (DirecNet) Study Group. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-Anhydroglucitrol, and continuous glucose monitoring. Pediatr Diabetes. 2011;12:690-595.
28. Koga M, Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr J. 2010;57:751-762.
29. Juraschek SP, Steffes MW, Selvin E. Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose. Clin Chem. 2012;58:1648-1655.
30. Furusyo N, Koga T, AiM, et al. Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS). Diabetologia. 2011;54:3028-3036.
31. Ma X-J, Pan J-M, Bao Y-Q, et al. Combined assessment of glycated albumin and fasting plasma glucose improves the detection of diabetes in Chinese subjects. Clin Exp Pharmacol Physiol. 2010;37:974-979.
32. Selvin E, Rawlings AM, Grams M, et al. Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective color analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol. 2014;2:279-288.
33. Juraschek SP, Steffes MW, Miller ER, Selvin E. Alternative markers of hyperglycemia and risk of diabetes. Diabetes Care. 2012;35:2265-2270.
34. Garber AJ, Handelsman Y, Einhorn D, et al. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract. 2008;14:933-946.
35. Shima K, Abe F, Chikakiyo H, Ito N. The relative value of glycated albumin, hemoglobin A1c and fructosamine when screening for diabetes mellitus. Diabetes Res Clin Pract. 1989;7:243-250.
36. Furusyo N, Koga T, Ai M, et al. Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS). Diabetologia. 2011;54:3028-3036.
37. Li Q, Pan JM, Ma XJ, et al. Combined utility of hemoglobin A1c and glycated albumin in diabetic screening. Zhonghua Yi Xue Za Zhi. 2011;91:1813-1816.
38. Selvin E, Francis LM, Ballantyne CM, et al. Nontraditional markers of glycemia: associations with microvascular conditions. Diabetes Care. 2011;34:960-967.
39. Yang C, Li H, Wang Z, et al. Glycated albumin is a potential diagnostic tool for diabetes mellitus. Clin Med. 2012;12:568-571.
40. Malmström H, Walldius G, Grill V, Jungner I, Gudbjörnsdottir S, Hammar N. Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies-cross-sectional and longitudinal experience from the AMORIS cohort. PLOS ONE. 2014;9:e111463.
41. Koga M, Murai J, Morita S, Saito H, Kasayama S. Comparison of annual variability in HbA1c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus. J Diabetes Complications. 2013;27:211-213.
42. Takahashi S, Uchino H, Shimizu T, et al. Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of shortterm changes in glycemic control. Endocr J. 2007;54:139-144.
43. Won HK, Kim KJ, Lee BW, Kang ES, Cha BS, Lee HC. Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatments. Diabet Med. 2012;29:74-79.
44. Ogawa A1, Hayashi A, Kishihara E, Yoshino S, Takeuchi A, Shichiri M. New indices for predicting glycaemic variability. PLOS ONE. 2012;7:e46517.
45. Suwa T, Ohta A, Matsui T, et al. Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM). Endocr J. 2010;57:135-140.
46. Shima K, Komatsu M, Noma Y, Miya K. Glycated albumin (GA) is more advantageous than hemoglobin A1c for evaluating the efficacy of sitagliptin in achieving glycemic control in patients with type 2 diabetes. Intern Med. 2014;53:829-835.
47. Moura BP, Amorim PR, Silva BP, Franceschini SC, Reis JS, Marins JC. Effect of a short-term exercise program on glycemic control measured by fructosamine test in type 2 diabetes patients. Diabetol Metab Syndr. 2014;6:16.
48. Lindsey CC, Carter AW, Mangum S, et al. A prospective, randomized, multicentered controlled trial to compare the annual glycemic and quality outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care. Diabetes Technol Ther. 2004;6:370-377.
49. Yoshiuchi K, Matsuhisa M, Katakami N, et al. Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes. Endocr J. 2008;55:503-507.
50. Yogev Y, Hod M. Use of new technologies for monitoring and treating diabetes in pregnancy. Obstet Gynecol Clin North Am. 2007;34:241-253.
51. Koga M, Murai J, Saito H, et al. Glycated albumin levels are higher relative to glycated haemoglobin levels in gastrectomized subjects. Ann Clin Biochem. 2009;47:39-43.
52. Pu LJ, Lu L, Shen WF, et al. Increased serum glycated albumin level is associated with the presence and severity of coronary artery disease in type 2 diabetic patients. Circ J. 2007;71:1067-1073.
53. Inaba M, Okuno S, Kumeda Y, et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. J Am Soc Nephrol. 2007;18:896-903.
54. Fukuoka K, Nakao K, Morimoto H, et al. Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis. Nephrology (Carlton). 2008;13:278-283.
55. Nagayama H, Inaba M, Okabe R, et al. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test. Biomed Pharmacother. 2009;63:236-240.
56. Freedman BI, Andries L, Shihabi ZK, et al. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. Clin J Am Soc Nephrol. 2011;6:1635-1643.
57. Zheng CM, Ma WY, Wu CC, Lu KC. Glycated albumin in diabetic patients with chronic kidney disease. Clin Chim Acta. 2012;413:1555-1561.
58. Peacock TP, Shihabi ZK, Bleyer AJ, et al. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney Int. 2008;73:1062-1068.
59. Chen HS, Wu TE, Lin HD, et al. Hemoglobin A(1c) and fructosamine for assessing glycemic control in diabetic patients with CKD stages 3 and 4. Am J Kidney Dis. 2010;55:867-874.
60. Freedman BI, Shihabi ZK, Andries L, et al. Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease. Am J Nephrol. 2010;31:375-379.
61. Sany D, Elshahawy Y, Anwar W. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence. Saudi J Kidney Dis Transpl. 2013;24:260-273.
62. ShafiT, Sozio SM, Plantinga LC, et al. Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients. Diabetes Care. 2013;36: 1522-1533.
63. Nunoi K, Kodama T, Sato Y, et al. Comparison of reliability of plasma fructosamine and glycosylated hemoglobin assays for assessing glycemic control in diabetic patients on hemodialysis. Metabolism. 1991;40:986-989.
64. Morgan L, Marenah CB, Jeffcoate WJ, et al. Glycated proteins as indices of glycaemic control in diabetic patients with chronic renal failure. Diabet Med. 1996;13 514-519.
65. Joy MS, Cefalu WT, Hogan SL, et al. Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis. 2002;39:297-307.
66. Phelps RL, Honig GR, Green D, et al. Biphasic changes in haemoglobin A1c concentrations during normal human pregnancy. Am J Obstet Gynecol. 1983;147:651-653.
67. Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991-2002.
68. Hashimoto K, Noguchi S, Morimoto Y, et al. A1C but not serum glycated albumin is elevated in late pregnancy owing to iron deficiency. Diabetes Care. 2008;31:1945-1948.
69. Hashimoto K, Osugi T, Noguchi S, et al. A1C but not serum glycated albumin is elevated because of iron deficiency in late pregnancy in diabetic women. Diabetes Care. 2010;33: 509-511.
70. Pan J, Zhang F, Zhang L, Bao Y, Tao M, Jia W. Influence of insulin sensitivity and secretion on glycated albumin and hemoglobin A1c in pregnant women with gestational diabetes mellitus. Int J Gynaecol Obstet. 2013;121:252-256.
71. Khan HA, Sobki SH, Alhomida AS, Khan SA. Paired values of serum fructosamine and blood glucose for the screening of gestational diabetes mellitus: a retrospective study of 165 Saudi pregnant women. Indian J Clin Biochem. 2007;22:65-70.
72. Li K, Yang HX. Value of fructosamine measurement in pregnant women with abnormal glucose tolerance. Chin Med J (Engl). 2006;119:1861-1865.
73. Roberts AB, Baker JR. Serum fructosamine: a screening test for diabetes in pregnancy. Am J Obstet Gynecol. 1986;154: 1027-1030.
74. Frandsen EK, Sabagh T, Bacchus RA. Serum fructosamine in diabetic pregnancy. Clin Chem. 1988;34:316-319.